Gregory J. Flesher
2019 - Tokai Pharmaceuticals
In 2019, Gregory J. Flesher earned a total compensation of $842.7K as Chief Executive Officer at Tokai Pharmaceuticals, a 11% decrease compared to previous year.
Compensation breakdown
| Option Awards | $293,683 |
|---|---|
| Salary | $480,436 |
| Stock Awards | $66,847 |
| Other | $1,698 |
| Total | $842,664 |
Flesher received $480.4K in salary, accounting for 57% of the total pay in 2019.
Flesher also received $293.7K in option awards, $66.8K in stock awards and $1.7K in other compensation.
Rankings
In 2019, Gregory J. Flesher's compensation ranked 10,014th out of 13,971 executives tracked by ExecPay. In other words, Flesher earned more than 28.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,014 out of 13,971 | 28th |
Division Manufacturing | 4,042 out of 5,692 | 29th |
Major group Chemicals And Allied Products | 1,532 out of 2,189 | 30th |
Industry group Drugs | 1,310 out of 1,875 | 30th |
Industry Pharmaceutical Preparations | 974 out of 1,387 | 30th |
Source: SEC filing on March 31, 2020.
Flesher's colleagues
We found two more compensation records of executives who worked with Gregory J. Flesher at Tokai Pharmaceuticals in 2019.
News
Reneo Pharmaceuticals CEO Gregory Flesher's 2022 pay falls 78% to $1.2M
April 26, 2023
Reneo Pharmaceuticals CEO Gregory Flesher's 2021 pay jumps 3,939% to $5.4M
April 22, 2022
Tokai Pharmaceuticals CEO Gregory Flesher's 2019 pay slips 11% to $843K
March 31, 2020
Tokai Pharmaceuticals CEO Gregory Flesher's 2018 pay slips 2% to $943K
May 15, 2019